Wazir, N., and S. U. Rehman. “Efficacy and Safety of Empagliflozin As Add-On Therapy in Patients of Type-2 Diabetes Mellitus”. Journal of Gandhara Medical and Dental Science, vol. 9, no. 1, Jan. 2022, pp. 24-27, doi:10.37762/jgmds.9-1.173.